The bullish case for Applied Genetic Technologies Corp (NASDAQ: AGTC), a nano-cap biotech conducting human clinical trials of adeno-associated virus-based gene therapies, can be made on the basis of an encouraging pipeline and valuation reasons, according to Wells Fargo.
The Analyst
Wells Fargo. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to: